In order to survive to the exposure of DNA damaging agents, cells activate a complex response that coordinates the cellular metabolism, cell cycle progression, and DNA repair. Among many other events, recent evidence has described global changes in mRNA splicing in cells treated with genotoxic agents. Here, we explore further this DNA damage-dependent alternative splicing. Indeed, we show that both the splicing factor SF3B2 and the repair protein CtIP contribute to the global pattern of splicing both in cells treated or not to DNA damaging agents. Additionally, we focus on a specific DNA damage- and CtIP-dependent alternative splicing event of the helicase PIF1 and explore its relevance for the survival of cells upon exposure to ionizing ra...
During repair of DNA double-strand breaks, resection of DNA ends influences how these lesions will b...
After DNA damage, cells modulate pre-messenger RNA (pre-mRNA) splicing to induce an anti- or proapop...
Tumour hypoxia is associated with poor patient outcome and resistance to therapy. It is accompanied ...
In order to survive to the exposure of DNA damaging agents, cells activate a complex response that c...
Genome integrity is constantly threatened by endogenous and exogenous factors. However, its preserva...
The appropriate repair of DNA double strand breaks is critical for genome maintenance. Thus, several...
The number of factors known to participate in the DNA damage response (DDR) has expanded considerabl...
DNA suffers thousands of lesions from exogenous and endogenous sources. Nevertheless, double-strand...
Most human genes encode multiple mRNA variants and protein products through alternative splicing of ...
Defects in the regulation of alternative splicing have strong relevance in the onset and progression...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
SummaryAlternative splicing is a vast source of biological regulation and diversity that is misregul...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
There are emerging links between gene transcription and alternative pre-mRNA splicing. For example, ...
During repair of DNA double-strand breaks, resection of DNA ends influences how these lesions will b...
After DNA damage, cells modulate pre-messenger RNA (pre-mRNA) splicing to induce an anti- or proapop...
Tumour hypoxia is associated with poor patient outcome and resistance to therapy. It is accompanied ...
In order to survive to the exposure of DNA damaging agents, cells activate a complex response that c...
Genome integrity is constantly threatened by endogenous and exogenous factors. However, its preserva...
The appropriate repair of DNA double strand breaks is critical for genome maintenance. Thus, several...
The number of factors known to participate in the DNA damage response (DDR) has expanded considerabl...
DNA suffers thousands of lesions from exogenous and endogenous sources. Nevertheless, double-strand...
Most human genes encode multiple mRNA variants and protein products through alternative splicing of ...
Defects in the regulation of alternative splicing have strong relevance in the onset and progression...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
SummaryAlternative splicing is a vast source of biological regulation and diversity that is misregul...
Mutations within BRCA1 predispose carriers to a high risk of breast and ovarian cancers. BRCA1 funct...
There are emerging links between gene transcription and alternative pre-mRNA splicing. For example, ...
During repair of DNA double-strand breaks, resection of DNA ends influences how these lesions will b...
After DNA damage, cells modulate pre-messenger RNA (pre-mRNA) splicing to induce an anti- or proapop...
Tumour hypoxia is associated with poor patient outcome and resistance to therapy. It is accompanied ...